Osseo IQ
Chapter 4 · Surgical · §4.10

Wound Management & Flap Closure

Tension-free passivity, flap design and blood supply, and the management of dehiscence and barrier exposure.

Compiled by
Tan Khuu, DDS
Licensed dentist (CA & SC)
Audience
Oral surgeons, prosthodontists, periodontists & residents
Edition
1.0 · June 2026
Reviewed
June 2026 · next review June 2027
Reading time
~16 minutes
Evidence basis
Consensus statements + systematic reviews + primary literature
§4.10.1 — Overview

Why closure decides the outcome

Most wound complications in implant and regenerative surgery do not begin with the membrane, the graft, or the bug — they begin at the moment the flap is sutured under tension. The single strongest, most reproducible predictor of uneventful guided-bone-regeneration (GBR) healing is passive, tension-free primary closure: a flap that rests over the augmented site without retracting and without being held there by the sutures.1 Everything else in this chapter — flap design, the periosteal releasing incision, suture selection, and the algorithm for managing a wound that has opened — exists to serve that one principle or to rescue the situation when it has not been achieved.

The logic is mechanical before it is biological. A flap closed under tension stores elastic energy that is released slowly over the first postoperative days as edema rises; the margin separates, the underlying barrier or graft is exposed to the oral environment, and the regenerative compartment is contaminated. Because exposure compromises the very space GBR depends upon, premature membrane exposure consistently and significantly reduces the bone gained.3 The clinician therefore works the problem from two directions: prevention through flap design and passive closure, and salvage through a disciplined, scenario-specific response to dehiscence and exposure that hinges on two questions — is a barrier membrane exposed, and is there infection?

Tension is the wound's enemy; passivity is the surgeon's only durable defense against exposure.
◆ Key concept · Passivity is a test, not a hope

A flap is passive only if it can be proven so before suturing. Drape the mobilized flap over the augmented site and release it: a passive flap stays put and overlaps the opposing margin without springing back. If it retracts, it is not ready — extend the release, do not borrow tension from the sutures. Suture tension is a temporary loan against an account that empties as edema swells; passivity is paid-up capital. Membrane brand, suture material, and antibiotics are all secondary to this single mechanical fact.

§4.10.2 — Principles of closure

Flap design, blood supply & advancement

A flap is a vascular structure first and a covering second. It is raised full-thickness (mucoperiosteal) so that the periosteum and its blood supply travel with it, and it is designed with a base wider than its margin so that perfusion to the wound edge is never strangled. Where esthetics matter, the design is papilla-sparing; where vertical releasing incisions are needed, they are divergent (running apically away from each other), placed at line angles rather than through papillae, and carried past the mucogingival junction into the elastic mucosa where the tissue can actually be mobilized. Incisions are kept off the graft and membrane themselves, so that the suture line rests over sound bone, not over the regenerative compartment.1

Advancement — the conversion of a tethered flap into a mobile one — is achieved by the periosteal releasing incision. The periosteum is the inelastic inner lamina of the flap; the overlying mucosa is elastic. By scoring through the periosteum only, at the base of the flap, the inelastic layer is divided and the elastic mucosa is freed to stretch coronally. The incision is deliberately shallow — on the order of 0.5 mm, through periosteum alone — and is followed by gentle blunt undermining to mobilize the flap without cutting muscle or vessels.2 In the posterior mandible the maneuver demands particular respect for the mental nerve and submental vasculature; the modified periosteal releasing incision was developed precisely to obtain advancement with a lower risk of these injuries.2

Suturing then distributes the work between two suture types. Horizontal mattress sutures, placed a few millimeters from the margin, bear the residual tension and evert the wound edges to bring broad connective-tissue surfaces into contact — the configuration that creates a tight seal. Interrupted sutures are then placed at the margin itself only to approximate the edges precisely. The governing rule is that tension is borne by the mattress, never by the margin; a margin suture under load will cheese-wire through the tissue and reopen the wound. Non-resorbable sutures are removed at roughly seven to fourteen days once the edge has sealed.

Before release — flap is tethered After periosteal release — flap advances host bone barrier + graft inelastic periosteum (intact) retracts — exposure gap host bone barrier + graft (covered) periosteal releasing incision (~0.5 mm) advances — passive coverage mattress bears tension · interrupted approximates periosteum / releasing incision barrier membrane graft advanced flap
Figure 1. The periosteal releasing incision and tension-free flap advancement. Left: an unreleased mucoperiosteal flap is tethered by its inelastic periosteum and retracts, leaving an exposure gap over the barrier and graft. Right: a shallow (~0.5 mm) periosteal releasing incision divides the periosteum, freeing the elastic mucosa to advance coronally for passive, overlapping coverage; horizontal mattress sutures bear the residual tension while interrupted sutures approximate the margin. Original schematic.2
Table 1 · Suture material selection for implant & regenerative wounds
MaterialResorbable?HandlingTypical use / notes
ePTFE (e.g., Gore-Tex suture)NoMonofilamentVery low plaque affinity; excellent for GBR & esthetic primary closure
PTFE (monofilament)NoMonofilamentNon-wicking, soft-tissue friendly; remove ~10–14 days
Silk (braided)NoBraidedEasy handling but wicks plaque/bacteria — avoid over grafts
Polyglycolic acid / VicrylYesBraidedResorbable; convenient where suture removal is difficult
Chromic gutYesMonofilamentFast resorption; less predictable tensile retention

Sizing. Use 4-0 for the flap body and posterior sites where strength matters; step down to 5-0–6-0 for esthetic and papilla approximation. Whatever the gauge, bear tension on the mattress sutures and keep the margin passive.

✦ Clinical pearl · Don't over-contour the graft

A graft mounded higher than the surrounding ridge re-introduces the very tension the releasing incision was meant to eliminate — the flap must now stretch over a taller dome. Contour particulate grafts to a contained, anatomically reasonable volume, confirm passivity after the graft is in place (not before), and choose a space-maintaining membrane rather than an over-packed graft when vertical gain is the goal.

▲ Common pitfalls
  • Borrowing tension from sutures instead of releasing the periosteum — the margin separates as edema peaks on days 2–4.
  • Placing vertical releasing incisions through papillae or directly over the membrane, devascularizing the margin and seating the suture line over the regenerative compartment.
  • Cutting too deep during the releasing incision in the posterior mandible, risking hemorrhage or mental-nerve injury.
  • Using braided silk over a graft, where it wicks plaque and bacteria into the wound.
§4.10.3 — Managing dehiscence & exposure

When the wound opens

When a wound dehisces, the management is governed by two questions answered at the chairside: is a barrier membrane exposed, and is there infection? The answers sort every presentation into one of four scenarios, each with its own protocol. The unifying biology is that the barrier's tolerance of exposure is a function of its porosity, and that infection — not exposure per se — is what forces removal.3

A resorbable collagen membrane with a small, non-infected exposure is the most forgiving case: native and cross-linked collagen tolerate limited exposure and frequently heal by secondary intention, so management is conservative — antiseptic control with chlorhexidine and protection from trauma, never re-suturing under tension over a granulating wound. An exposed high-density PTFE (d-PTFE) membrane in the absence of infection is, by design, a manageable event: its sub-micron porosity (pores roughly 0.2 µm) is impervious to bacteria, so the membrane is left in situ, maintained with chlorhexidine rinse and gel and meticulous hygiene, monitored weekly, and removed at the planned interval — often around three to four weeks for an exposed d-PTFE.3 By contrast, an exposed expanded PTFE (e-PTFE) membrane, or any membrane accompanied by suppuration or spreading infection, must be removed: porous e-PTFE wicks bacteria once exposed, and an infected barrier jeopardizes both the graft and the host bone — remove promptly, debride and irrigate, salvage incorporated graft, add culture-guided systemic antibiotics for spreading or systemic signs, and re-plan augmentation later. Finally, a flap dehiscence without an exposed barrier — a soft-tissue opening over a cover screw or particulate graft — is managed with local care and secondary healing: chlorhexidine, hygiene optimization, protection of the site, and reassessment of soft-tissue grafting once the wound has closed.

Table 2 · Exposure-management matrix — barrier type × infection status
ScenarioKey featureActionEvidence
Resorbable (collagen), small exposure, no pusCollagen tolerates limited exposureConservative: 0.12% CHX rinse + gel; protect; allow secondary epithelialization; do not re-suture under tensionConsensus
Exposed d-PTFE, no infection~0.2 µm pores resist bacterial ingress; designed to tolerate exposureMaintain in situ; CHX rinse + 1% CHX gel; weekly monitoring; planned removal (~3–4 wk)Syst. review
Infected membrane, or exposed e-PTFEPorous e-PTFE wicks bacteria; infection threatens graft + host boneRemove promptly; debride/irrigate; salvage incorporated graft; culture-guided systemic antibiotics if spreading; re-planSyst. review
Flap dehiscence, no barrier exposedSoft-tissue opening over cover screw or graftLocal care: CHX rinse/gel; hygiene; secondary healing; reassess soft-tissue graft once healedConsensus

Exposure-management selector

Identify the scenario that matches your postoperative finding to review the recommended protocol. Management hinges on two questions: is a barrier membrane exposed, and is there infection?

Tap the scenario that matches your post-op finding.

✦ Clinical pearl · d-PTFE exposure is a plan, not a panic

A non-infected d-PTFE exposure is a foreseeable, manageable event — not a complication that demands re-entry. Its low porosity (~0.2 µm) excludes bacteria, so the correct response is to defend the surface with chlorhexidine rinse and gel and meticulous hygiene, monitor weekly, and remove the membrane at the intended interval. Resist the urge to force tissue closed over it under tension; doing so simply trades a clean exposure for a fresh dehiscence.

▲ Common pitfall · Treating all exposures alike

The most consequential error is failing to distinguish d-PTFE from e-PTFE and colonized from infected. Leaving an exposed, porous e-PTFE membrane — or any membrane with suppuration — under chlorhexidine alone allows bacterial ingress to destroy the graft and resorb host bone. Conversely, prematurely removing an uninfected d-PTFE forfeits regeneration that would have completed. Characterize the membrane and the infection status first; the protocol follows from that, not from the size of the opening alone.

§4.10.4 — Glossary

Key terms

Passive (tension-free) closure
A flap that rests over the wound and overlaps the opposing margin without retracting and without tension borne by the sutures — the strongest predictor of uneventful GBR healing.
Mucoperiosteal (full-thickness) flap
A flap raised to include epithelium, connective tissue, and periosteum, carrying the periosteal blood supply with it.
Periosteal releasing incision
A shallow (~0.5 mm) incision through the inelastic periosteum at the flap base that frees the elastic mucosa to advance coronally for tension-free coverage.
Horizontal mattress suture
A suture placed away from the margin that bears wound tension and everts the edges to appose broad connective-tissue surfaces, creating a seal.
Dehiscence
Postoperative separation of a previously approximated wound margin.
d-PTFE (high-density PTFE)
A non-resorbable barrier with sub-micron pores (~0.2 µm) impervious to bacteria; designed to tolerate intentional or incidental exposure.
e-PTFE (expanded PTFE)
A porous non-resorbable barrier (pores ~0.5–30 µm) that wicks bacteria once exposed and must be removed if exposed or infected.
Secondary intention healing
Wound closure by granulation and epithelialization across an open margin, rather than by primary apposition.
§4.10.S — Self-test

Self-Test

1. The single most important determinant of uneventful primary wound healing over a GBR site is:
B is correct. Passive, tension-free closure is the strongest predictor of GBR success; residual tension is the leading cause of dehiscence and membrane exposure. Membrane choice, suture type, and antibiotics are secondary.
2. To advance a mucoperiosteal flap for tension-free closure, the recommended maneuver is:
A is correct. A shallow (~0.5 mm) periosteal releasing incision at the base, with blunt undermining, releases the inelastic periosteum and advances the flap. Deep incisions risk hemorrhage/nerve injury; cutting keratinized tissue or papillae harms blood supply and esthetics.
3. A high-density PTFE (d-PTFE) membrane becomes exposed at 2 weeks with no signs of infection. The best initial management is to:
A is correct. d-PTFE has ~0.2 µm pores that resist bacterial ingress and is designed to tolerate exposure. Manage with 0.12% chlorhexidine rinse plus gel and meticulous hygiene, monitor, and remove at the planned interval.
4. An exposed expanded-PTFE (e-PTFE) membrane now shows suppuration and surrounding erythema. The correct action is to:
B is correct. Porous e-PTFE wicks bacteria once exposed; an infected membrane must be removed promptly with debridement and infection control (culture-guided systemic antibiotics if spreading). Leaving it risks loss of graft and host bone.
5. A full-thickness flap is designed with its base wider than its margin primarily to:
B is correct. A broad base protects perfusion to the flap margin; a narrow base relative to the margin risks ischemia and marginal necrosis, predisposing to dehiscence.
6. The recommended depth of a periosteal releasing incision is approximately:
B is correct. The incision should divide the inelastic periosteum only (~0.5 mm), followed by blunt undermining. Deeper incisions risk hemorrhage and nerve injury, particularly in the posterior mandible.
7. In a layered closure, wound tension should be borne primarily by:
B is correct. Horizontal mattress sutures, placed away from the margin, carry tension and evert the edges; interrupted sutures then only approximate the margin. A loaded margin suture cheese-wires through tissue and reopens the wound.
8. Premature exposure of a barrier membrane during GBR is most associated with:
B is correct. Systematic review and meta-analysis show membrane exposure significantly reduces bone gain. Preventing exposure through passive closure is therefore central to GBR success.
9. A small dehiscence over a native collagen membrane with no pus is best managed by:
A is correct. Collagen tolerates limited exposure and often heals by secondary intention. Manage with chlorhexidine and gentle plaque control; do not re-suture a granulating wound under tension.
10. The principal reason d-PTFE tolerates exposure better than e-PTFE is:
B is correct. d-PTFE's pores (<0.3 µm) are smaller than bacteria (~0.5–5 µm), so the surface resists bacterial ingress when exposed. e-PTFE pores (~0.5–30 µm) permit bacterial penetration.
11. Vertical releasing incisions are best placed:
C is correct. Divergent releasing incisions at line angles preserve papillae and blood supply, and extending past the MGJ into elastic mucosa allows true mobilization. Incisions over the graft seat the suture line on the regenerative compartment.
12. Which suture material is least appropriate over a GBR graft because it wicks plaque and bacteria?
C is correct. Braided silk handles easily but wicks plaque and bacteria along its filaments, making it a poor choice over grafts. Non-wicking monofilaments (PTFE, ePTFE) are preferred for regenerative closure.
13. Non-resorbable sutures over an implant/GBR wound are typically removed at:
B is correct. Non-resorbable sutures are generally removed around 7–14 days, once the margin has sealed; leaving them longer increases plaque accumulation along the suture track.
14. A flap dehiscence exposes a cover screw but no membrane, with no infection. Appropriate management is:
A is correct. Without an exposed barrier or infection, a soft-tissue opening over a cover screw or particulate graft is managed with chlorhexidine, hygiene, and secondary healing; reassess the need for a soft-tissue graft once healed.
15. The structure principally responsible for tethering a mucoperiosteal flap and limiting its advancement is:
B is correct. The periosteum is the inelastic inner lamina; dividing it with a shallow releasing incision frees the elastic mucosa to stretch coronally and advance the flap.
16. The first step when any wound dehisces over a regenerative site is to:
B is correct. Management hinges on two questions — is a barrier exposed, and is there infection? The protocol follows from the answers, not from the size of the opening alone.
17. An exposed d-PTFE membrane is typically removed at approximately:
B is correct. An exposed but uninfected d-PTFE is maintained with chlorhexidine and removed at the planned interval, often around 3–4 weeks, by which time adequate osteoid has formed beneath it.
18. Systemic antibiotics in the management of an exposed membrane are most clearly indicated when there is:
B is correct. Systemic antibiotics are reserved for spreading or systemic infection and are ideally culture-guided. Routine antibiotics for an uninfected exposure are not indicated; local antiseptic control is the mainstay.
19. When an infected membrane is removed, incorporated graft material should be:
B is correct. At removal, salvage graft that has incorporated into host bone and curette loose, non-integrated particles; debride and irrigate, then allow soft-tissue healing and re-plan augmentation later.
20. The objective test that a flap is passive before suturing is that it:
B is correct. Passivity is confirmed by draping the mobilized flap over the site: it should rest there and overlap the opposing margin without being held and without retracting. If it springs back, extend the release rather than relying on suture tension.
1. Walk the examiner through how you achieve tension-free primary closure over a simultaneous GBR site, and how you confirm it.
Model answer. I raise a full-thickness mucoperiosteal flap with a broad base and, where needed, divergent vertical releasing incisions at line angles extending past the mucogingival junction into the elastic mucosa. I make a shallow periosteal releasing incision (~0.5 mm, through periosteum only) at the flap base and bluntly undermine to mobilize the mucosa. I confirm passivity by draping the flap over the augmented site — it should rest there and overlap the opposing margin without being held and without springing back. I then close with horizontal mattress sutures to bear tension and evert the margins, followed by interrupted sutures to approximate them, and I avoid over-contouring the graft, which re-introduces tension.
Examiner follow-ups:
  • How do you test passivity objectively?
  • What are the risks of a releasing incision in the posterior mandible?
  • Why bear tension on mattress rather than margin sutures?
2. A non-resorbable membrane is exposed at the two-week review. Take me through your decision-making.
Model answer. First I characterize it: which membrane — dense d-PTFE versus porous e-PTFE — and is there infection (pus, increasing pain or swelling)? A non-infected d-PTFE exposure I manage conservatively — leave it in situ, chlorhexidine rinse and gel, meticulous hygiene, weekly monitoring, and removal at the planned time — because its sub-micron porosity resists bacterial ingress. An exposed e-PTFE, or any membrane with suppuration or spreading infection, I remove promptly with debridement, salvaging graft that has incorporated, curetting loose particles, and adding culture-guided systemic antibiotics if there are systemic signs. I document and reset expectations on regenerated volume.
Examiner follow-ups:
  • Why does d-PTFE tolerate exposure but e-PTFE does not?
  • When would you start systemic antibiotics?
  • How does exposure affect the final bone gain?
3. Compare resorbable and non-resorbable membranes with respect to exposure risk and its consequences, and how that informs your choice.
Model answer. Resorbable collagen membranes carry a lower overall complication burden — exposures are often self-limiting, heal by secondary intention, and need no removal surgery — but they provide weaker space maintenance and suit contained, horizontal defects. Non-resorbable membranes (d-PTFE, titanium-reinforced PTFE) maintain space far better for vertical and large defects, but exposure is more consequential: e-PTFE in particular wicks bacteria and risks infection, and all require a second-stage removal. So I select collagen for contained defects favoring uneventful healing, and reserve titanium-reinforced or d-PTFE for demanding space-maintenance cases where I can secure robust tension-free primary closure.
Examiner follow-ups:
  • Which membrane would you choose for vertical augmentation, and why?
  • How much does exposure reduce regenerated bone volume?
  • What flap or closure modifications reduce exposure risk for non-resorbable membranes?
4. A patient has a flap dehiscence over a particulate graft at one week, with no exposed membrane and no infection. Justify your management and your prognosis.
Model answer. A soft-tissue opening over a cover screw or particulate graft without an exposed barrier or infection is managed with local care and healing by secondary intention. I prescribe a chlorhexidine rinse and gel, optimize plaque control, remove plaque-retentive factors, and protect the site from trauma and brushing. If superficial graft particles slough at the margin, I reassure the patient and monitor the regenerated volume rather than intervening. I re-evaluate the need for a soft-tissue graft once the wound has epithelialized. The prognosis is generally favorable provided the deeper graft compartment stays uninfected; I counsel that some surface volume may be lost but that the contained graft typically consolidates.
Examiner follow-ups:
  • What would change your management to surgical re-entry?
  • How do you decide whether a soft-tissue graft is needed afterward?
  • What hygiene instructions do you give over a healing-by-secondary-intention site?
5. Defend the statement that "tension, not the membrane, decides the fate of a GBR site," and explain how you operationalize it.
Model answer. Most exposures begin mechanically: a flap closed under tension stores elastic energy that is released as edema rises over the first postoperative days, the margin separates, and the barrier or graft is exposed and contaminated — and exposure, in turn, significantly reduces bone gain. So the membrane rarely fails on its own merits; it fails because the soft-tissue envelope failed first. I operationalize this by building every closure around passivity: full-thickness flaps with broad bases, divergent releasing incisions past the mucogingival junction, a shallow periosteal releasing incision with blunt undermining, an objective passivity check before suturing, mattress sutures to bear tension with interrupted sutures only to approximate, non-wicking monofilament over grafts, and a contoured (not over-packed) graft. When a wound still opens, I triage by barrier type and infection status rather than by panic, because that two-question framework — exposed barrier? infected? — predicts the correct salvage.
Examiner follow-ups:
  • What is the evidence that exposure reduces bone gain?
  • Which single technical step most reduces exposure risk?
  • How does graft over-contouring undermine an otherwise passive flap?
§4.10 — References

References

  1. Burkhardt R, Lang NP. Coverage of localized gingival recessions: comparison of micro- and macrosurgical techniques. J Clin Periodontol. 2005;32(3):287–293. doi:10.1111/j.1600-051X.2005.00660.x
  2. Hur Y, Bui MN, Griffin TJ, Ogata Y. Modified periosteal releasing incision for flap advancement: a practical technique for tensionless closure. Clin Adv Periodontics. 2015;5(4):229–234. doi:10.1902/cap.2014.140009
  3. Garcia J, Dodge A, Luepke P, Wang HL, Kapila Y, Lin GH. Effect of membrane exposure on guided bone regeneration: a systematic review and meta-analysis. Clin Oral Implants Res. 2018;29(3):328–338. doi:10.1111/clr.13121

Evidence grades: Systematic review Consensus Preclinical.

About this chapter

This chapter is part of Osseo IQ — a clinical reference for implant dentistry. Content is sourced from consensus statements, systematic reviews, and primary literature; each key recommendation carries an evidence grade, and every page records its review date. Material is reviewed on a rolling annual cycle.

How to cite: Khuu T, ed. Wound Management & Flap Closure. In: Osseo IQ, 1st ed. §4.10. June 2026. Accessed [date]. [URL]

Compiled by: Tan Khuu, DDS — Doctor of Dental Surgery and a licensed dentist in California and South Carolina. Osseo IQ summarizes published evidence and clinical guidelines and is not a substitute for individual clinical judgment. Image credits: Figure 1 original schematic illustration © Osseo IQ, 2026.

For licensed clinicians — educational use only. This chapter summarizes published evidence and is not a substitute for individual clinical judgment, examination, or the standard of care in your jurisdiction. Verify drug doses, devices, and protocols against current manufacturer instructions and local guidelines.

© 2026 Osseo IQ · Edition 1.0 · Chapter 4 Surgical · §4.10 · Last reviewed June 2026